Cancer/Radiotherapie

Top Research Topics at Cancer Radiotherapie?

Cancer Radiotherapie focuses on Radiation therapy, Gynecology, Nuclear medicine, Radiology and Internal medicine. The journal holds forums on Radiation therapy that merges themes from other disciplines such as Cancer, Breast cancer and Chemotherapy. The Gynecology study featured in Cancer Radiotherapie draws parallels with the field of Combined treatment.

Most of the works presented in the journal deals with Nuclear medicine but it intersects with the subject of Planning target volume. It connects the study in Internal medicine with the closely related area of Oncology.

• Radiation therapy (22.43%)
• Gynecology (11.26%)
• Nuclear medicine (10.60%)

What are the most cited papers published in the journal?

• Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta analysis of chemotherapy on head and neck cancer (589 citations)
• Non small cell lung cancer (374 citations)
• Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer (339 citations)

Research areas of the most cited articles at Cancer Radiotherapie:

The most cited papers tackle a plethora of topics, such as Radiation therapy, Nuclear medicine, Surgery, Gynecology and Radiology. The published papers facilitate discussions on Radiation therapy that incorporate concepts from other fields like Cancer, Prostate cancer and Oncology. The published articles focus on Nuclear medicine but the discussions also offer insight into other areas such as Head and neck, Tomotherapy, Planning target volume and Prostate.

What topics the last edition of the journal is best known for?

• Cancer
• Internal medicine
• Surgery

The previous edition focused in particular on these issues:

Cancer Radiotherapie investigates areas of study like Radiation therapy, Radiology, Internal medicine, Gynecology and Oncology. Cancer Radiotherapie facilitates discussions on Radiation therapy that incorporate concepts from other fields like Cancer, Breast cancer, Regimen, Nuclear medicine and Stage (cooking). The studies on Nuclear medicine discussed can also contribute to research in the domains of Radiation treatment planning, Tomotherapy and Prostate.

The journal tackles research in various disciplines, including Gynecology and Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While work presented in the journal provided substantial information on Oncology, it also covered topics in Locally advanced and Standard treatment. The presented research on Brachytherapy deals specifically with Prostate cancer but it also addresses topics in Planning target volume.

The most cited articles from the last journal are:

• Evaluating cardiac substructure radiation exposure in breast rotational intensity modulated radiation therapy: Effects of cancer laterality, fractionation and deep inspiration breath-hold. (7 citations)
• Clinical practice of breast cancer protontherapy: A single-centre experience from selection to treatment. (4 citations)
• Clinical and technical considerations for mediastinal Hodgkin lymphoma protontherapy based on a single-center early experience. (3 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Cancer Radiotherapie (based on the number of publications) are:

• Didier Peiffert (159 papers) published 6 papers at the last edition, 3 more than at the previous edition,
• Georges Noël (157 papers) published 2 papers at the last edition, 4 less than at the previous edition,
• Françoise Mornex (143 papers) published 3 papers at the last edition,
• R. de Crevoisier (124 papers) published 4 papers at the last edition, 3 less than at the previous edition,
• D. Azria (123 papers) published 1 paper at the last edition, 6 less than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Cancer Radiotherapie (based on the number of publications) are:

• Institut Gustave Roussy (454 papers) published 20 papers at the last edition, 1 less than at the previous edition,
• Curie Institute (357 papers) published 30 papers at the last edition, 6 more than at the previous edition,
• French Institute of Health and Medical Research (221 papers) published 8 papers at the last edition, 11 less than at the previous edition,
• University of Paris (83 papers) published 10 papers at the last edition, 15 less than at the previous edition,
• Centre national de la recherche scientifique (74 papers) published 3 papers at the last edition, 3 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 29.11% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 58.93% were posted by at least one author from the top 10 institutions publishing in the journal. Another 6.25% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 8.93% of all publications and 25.89% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Cancer Research and Oncology

With a wide range of research topics being focused on, there are equally as many career paths within the field of cancer research and oncology. Many professionals find their passion in the research, diagnosis, and treatment of cancer, extending their practice in hospitals, laboratories, and academic institutions where they can employ their expertise.

One significant role in the field is a Nurse Practitioner specialized in oncology. They are registered nurses who further their education and clinical training to assume responsibilities such as diagnosing and managing patients' health conditions, including cancer. They can also work as a healthcare researcher in settings like Cancer Radiotherapie, contributing to cancer-related topics such as Radiation therapy, Gynecology, Nuclear medicine, Radiology, and Internal medicine.

For individuals who wish to explore this career path further, understanding the process to become a specialist, such as a Nurse Practitioner in Oncology, can be greatly beneficial. The journey involves obtaining a Bachelor's degree in Nursing (BSN), gaining a registered nursing license, getting real-world experience, and continuing education to earn a Master's degree. With additional specialized training and experience, nurses can enhance their career. You can find more information on how to embark on this journey on our detailed guide on how to become a nurse practitioner in Texas.

The field of cancer research and oncology offers a variety of career paths, allowing professionals to find their niche and contribute to evolving research and patient care.